Skip to main content
. 2021 Nov-Dec;11(6):599–609. doi: 10.22038/AJP.2021.18526

Figure 3.

Figure 3

The effect of quercetin on path length on 6-OHDA-induced memory impairment in the control, sham, Parkinson's disease (PD) and quercetin 10 (Q10) and 25 mg/kg (Q25)- treated groups (**P<0.01, ***p<0.001, PD vs. sham and control groups, and &&& p<0.001, Q10 and Q25 vs. PD group). Two-way ANOVA repeated measurements, followed by Tukey’s post hoc tests